Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al
| AMAG Pharmaceuticals, Inc., AMAG Pharma USA, Inc. and Covis Pharma GmbH |
| Aurobindo Pharma, Ltd., Aurobindo Pharma U.S.A., Inc. and Eugia Pharma Specialties Ltd. |
| 1:2021cv00003 |
| January 4, 2021 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 6, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 6 Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 24, 2020. Date of Expiration of Patent: May 2, 2036.Thirty Month Stay Deadline: 5/24/2023. (Grivner, Geoffrey) |
| Filing 5 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,844,558 ;10,471,075 . (Grivner, Geoffrey) |
| No Summons Issued. (mal) |
| Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Covis Holdings US, Inc for AMAG Pharmaceuticals, Inc.; Corporate Parent AMAG Pharmaceuticals, Inc. for AMAG Pharma USA, Inc.; Corporate Parent Covis Pharma BV for Covis Pharma GmbH. Apollo Management, L.P. owns 10% or more of the stock of Covis PharmaGmbH, AMAG Pharma USA, Inc., and AMAG Pharmaceuticals, Inc., via theirparent corporations filed by AMAG Pharma USA, Inc., AMAG Pharmaceuticals, Inc., Covis Pharma GmbH. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 24, 2020. Date of Expiration of Patent: May 2, 2036.Thirty Month Stay Deadline: May 25, 2023. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT filed against Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma, Ltd., Eugia Pharma Specialties Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3439213.) - filed by Covis Pharma GmbH, AMAG Pharma USA, Inc., AMAG Pharmaceuticals, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
